Interleukin-4 (IL-4) as a Marker of Atherosclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00256035
Recruitment Status : Withdrawn
First Posted : November 21, 2005
Last Update Posted : April 27, 2015
The Intensive Care Unit Departmental Funding
Information provided by:
Melbourne Health

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Primary Completion Date : No date given
  Study Completion Date : No date given